Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$723K Sell
10,737
-1,275
-11% -$84.9K 0.11% 225
2026
Q1
$754K Sell
12,012
-6,784
-36% -$472K 0.15% 192
2025
Q4
$1.25M Buy
+18,796
New +$1.22M 0.24% 150
2025
Q2
Sell
-18,077
Closed -$1.23M 338
2025
Q1
$1.23M Buy
+18,077
New +$1.48M 0.37% 102
2024
Q4
Sell
-11,317
Closed -$759K 300
2024
Q3
$759K Buy
11,317
+5,852
+107% +$481K 0.3% 127
2024
Q2
$620K Buy
+5,465
New +$691K 0.28% 133
2019
Q2
Sell
-1,368
Closed -$41K 524
2019
Q1
$41K Buy
+1,368
New +$48.1K 0.02% 368

Other funds holding DXCM

Machina Capital's DXCM Position: Q2 2026 in Review

Machina Capital reduced its DexCom (DXCM) stake by 11% in Q2 2026, selling an estimated $84.9K and leaving 10,737 shares worth $723K. The position accounts for 0.11% of the portfolio, ranked #225.

Machina Capital first reported a position in DXCM in Q1 2019 and has held it in 7 quarters since. The position peaked at $1.25M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Machina Capital held 10,737 shares of DexCom worth $723K as of Q2 2026.
  • Machina Capital sold 1,275 DexCom shares in Q2 2026, an estimated $84.9K.
  • DexCom made up 0.11% of Machina Capital's portfolio in Q2 2026, its #225 holding.
  • Machina Capital first reported a position in DexCom in Q1 2019 and has held it in 7 quarters since.
  • Machina Capital's DexCom position peaked at $1.25M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.